Aris Mining Corporation (ARMN)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,420	599	454	337	414	391
Market Cap Growth	88.80%	31.84%	34.83%	-18.61%	5.92%	70.91%
Enterprise Value	1,916	1,137	621	446	396	376
Last Close Price	8.01	3.50	3.29	2.49	4.13	5.95
PE Ratio	279.39	24.35	39.76	-	2.22	-
PS Ratio	2.20	1.17	1.01	0.84	1.08	1.04
PB Ratio	1.16	0.55	0.73	0.68	0.87	1.99
P/TBV Ratio	1.53	0.75	0.73	0.68	0.87	2.54
P/FCF Ratio	37.91	-	-	-	24.22	6.14
P/OCF Ratio	5.49	4.24	4.34	4.38	5.14	2.86
EV/Sales Ratio	2.96	2.23	1.39	1.11	1.03	1.00
EV/EBITDA Ratio	7.84	7.47	4.04	2.68	2.32	2.12
EV/EBIT Ratio	9.38	9.62	5.31	3.37	2.86	2.45
EV/FCF Ratio	51.15	-	-	-	23.17	5.92
Debt / Equity Ratio	0.43	0.48	0.61	0.88	0.67	0.74
Debt / EBITDA Ratio	2.13	3.42	2.49	2.62	1.87	0.81
Debt / FCF Ratio	13.90	-	-	-	18.62	2.28
Asset Turnover	0.32	0.31	0.35	0.36	0.46	0.74
Inventory Turnover	6.77	7.45	7.99	7.99	6.97	6.69
Quick Ratio	1.81	2.23	1.68	2.40	5.60	0.82
Current Ratio	2.15	2.61	1.99	2.60	6.05	1.84
Return on Equity (ROE)	0.40%	2.73%	2.04%	-1.00%	53.34%	-17.57%
Return on Assets (ROA)	6.38%	4.41%	5.63%	7.38%	10.49%	18.98%
Return on Capital (ROIC)	7.96%	5.66%	7.54%	9.57%	15.20%	34.77%
Return on Capital Employed (ROCE)	10.20%	6.40%	9.70%	12.10%	14.80%	32.50%
Earnings Yield	0.36%	4.11%	2.51%	-1.44%	45.01%	-1.19%
FCF Yield	2.64%	-9.03%	-3.47%	-11.73%	4.13%	16.28%
Dividend Yield	-	-	-	4.01%	3.45%	0.59%
Payout Ratio	-	-	-	-	6.17%	-
Buyback Yield / Dilution	-23.33%	-15.78%	-17.31%	-23.14%	-56.32%	-22.69%
Total Shareholder Return	-23.33%	-15.78%	-17.31%	-19.13%	-52.87%	-22.10%

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q